This study was designed to elucidate hemostatic and genetic characteristics associated with thrombosis of the left atrial appendage (LAA) in patients with chronic atrial fibrillation (AF). It included 91 patients (mean age 62 ± 7.6 years) with coronary heart disease (CHD) and chronic AF. Group I was comprised of 63 patients without LAA thrombosis, group 2 contained 28 patients with LAA thrombosis diagnosed by transesophageal echocardiography. The following parameters were measured: soluble fibrin monomeric complex, fibrinogen, antithrombin, thrombin-activated fibrinolysis inhibitor levels and polymorphism of YP29, VKORC1, PAI-1 genes. Multifactor regression analysis revealed significant association of LAA thrombosis with thrombin-activated fibrinolysis inhibitor level in excess of 245%, the presence of CC genotype of the VKORC1 gene and 4G allele of the PAl-1 gene.

Download full-text PDF

Source

Publication Analysis

Top Keywords

laa thrombosis
12
associated thrombosis
8
thrombosis left
8
left atrial
8
atrial appendage
8
patients chronic
8
chronic atrial
8
patients laa
8
thrombin-activated fibrinolysis
8
fibrinolysis inhibitor
8

Similar Publications

To investigate whether we can rule out the left atrial appendage (LAA) thrombus in patients with atrial fibrillation (AF) using different scanning protocol by Cardiovascular Computed Tomography (CCT). We retrospectively reviewed the CCT images of 138 patients with AF to assess LAA thrombus. Patients with no thrombosis diagnosed by preoperative CCT should be confirmed using intraoperative findings as the reference standard.

View Article and Find Full Text PDF

Identifying left atrium and left atrial appendage prone to thrombus formation in patients with atrial fibrillation using statistical shape modeling.

Int J Cardiol

February 2025

Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, State Key Laboratory of Transvascular Implantation Devices, Hangzhou 310009, China. Electronic address:

Background: The morphology of the left atrium (LA) and left atrial appendage (LAA) is associated with LAA thrombus formation (LAAT) in patients with atrial fibrillation (AF). Statistical shape modeling (SSM) could be a comprehensive and objective method for evaluating LA/LAA shape, thereby improving LAAT risk assessment.

Methods And Results: In this individual-matched case-control study, 110 pairs of AF patients with or without LAAT were compared.

View Article and Find Full Text PDF

Management of giant left atrial thrombus late after transcatheter mitral valve-in-ring replacement using a transcatheter aortic valve: a case report.

BMC Cardiovasc Disord

November 2024

Department of Internal Medicine I, Cardiology, Angiology, Intensive Medical Care, University Hospital Jena, Am Klinikum 1, 07747, Jena, Germany.

Background: In symptomatic high-risk patients with severe mitral valve regurgitation (MR), who are not eligible for surgery, Transcatheter edge-to-edge repair (TEER) or transcatheter mitral valve replacement (TMVR) may be an option, especially when surgical mitral valve repair by annuloplasty has been performed earlier. After TMVR, the appropriate anticoagulation regimen is still matter of debate.

Case Presentation: We here report on a 78-year-old frail lady with heart failure and atrial fibrillation who underwent surgical reconstruction of the mitral valve nine years ago.

View Article and Find Full Text PDF

Background: Patients with atrial fibrillation and malignant left atrial appendage (LAA) may benefit from LAA closure (LAAC); however, evidence is limited.

Objective: The purpose of this study was to determine management strategies and clinical outcomes in patients with atrial fibrillation and malignant LAA.

Methods: Malignant LAA was defined as a history of ischemic stroke and/or evidence of LAA thrombus despite continuous oral anticoagulation (OAC) therapy (continuous for ≥3 weeks).

View Article and Find Full Text PDF
Article Synopsis
  • A systematic review examined left atrial mechanics in patients with atrial fibrillation (AF) about to undergo electrical cardioversion (ECV), focusing on the effect of AF on left atrial reservoir strain (LASr).
  • The analysis included 12 studies with a total of 880 patients, revealing a high ECV success rate of 91.5%, but highlighted that 35.2% of patients experienced AF recurrence within a median follow-up of 5.4 months.
  • Key findings indicated that a lower LASr before ECV was linked to higher chances of cardioversion failure and AF recurrence, suggesting that measuring LASr could help predict AF relapse and assess thromboembolic risk in these patients. *
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!